Posted: 11/9/2007
Biological Product Shortages - Haemophilus b Conjugate Vaccine (PedvaxHIB) information
Posted: 11/9/2007
Background Information Regarding the ISBT Label - Updated
Posted: 11/8/2007
Compliance Program: Chapter 41 - Inspection of Tissue Establishments - Updated
Posted: 11/8/2007
Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use; Proposed Rule
Posted: 11/8/2007
Background Information Regarding the ISBT Label
Posted: 11/7/2007
FDA Public Workshop: Processing of Orthopedic, Cardiovascular, and Skin Allografts - Transcripts
Posted: 11/7/2007
Influenza Virus Vaccine 2007/2008 Season Lot Release Status - Update
Posted: 11/7/2007
Approved Biological NDA and ANDA Applications - Update
Posted: 11/6/2007, Updated through: 10/31/2007
Cleared Biological 510(k) Device Applications - Update
Posted: 11/6/2007, Updated through: 10/31/2007
Approved Biological Premarket Approval (PMA) Device Applications - Update
Posted: 11/6/2007, Updated through: 10/31/2007
Substantially Equivalent 510(k) Device - PROGESA 4.4h - MAK-System
Posted: 11/6/2007, Clearance Date: 10/26/2007
Vacancy Announcement - Chemist PQLS/DPQ/OVRR
Posted: 11/6/2007
Tissue Reference Group Annual Reports - FY 2007 Update
Posted: 11/5/2007
Workshop: Immune Correlates of Protection Against Influenza A Viruses in Support of Pandemic Vaccine Development - Agenda
Posted: 11/5/2007
